COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Tisagenlecleucel (Primary) ; Cyclophosphamide; Fludarabine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms COBALT
- 10 Jun 2017 Biomarkers information updated
- 01 Sep 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 01 Sep 2016 Status changed from not yet recruiting to recruiting.